Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited Fundamental Analysis
Krsnaa Diagnostics Limited (KRSNAA.BO) shows moderate financial fundamentals with a PE ratio of 22.21, profit margin of 10.49%, and ROE of 9.11%. The company generates $7.7B in annual revenue with strong year-over-year growth of 15.74%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 32.8/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze KRSNAA.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakKRSNAA.BO struggles to generate sufficient returns from assets.
Valuation Score
ExcellentKRSNAA.BO trades at attractive valuation levels.
Growth Score
ExcellentKRSNAA.BO delivers strong and consistent growth momentum.
Financial Health Score
ExcellentKRSNAA.BO maintains a strong and stable balance sheet.
Profitability Score
WeakKRSNAA.BO struggles to sustain strong margins.
Key Financial Metrics
Is KRSNAA.BO Expensive or Cheap?
P/E Ratio
KRSNAA.BO trades at 22.21 times earnings. This indicates a fair valuation.
PEG Ratio
When adjusting for growth, KRSNAA.BO's PEG of -4.43 indicates potential undervaluation.
Price to Book
The market values Krsnaa Diagnostics Limited at 1.93 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 6.80 times EBITDA. This is generally considered low.
How Well Does KRSNAA.BO Make Money?
Net Profit Margin
For every $100 in sales, Krsnaa Diagnostics Limited keeps $10.49 as profit after all expenses.
Operating Margin
Core operations generate 23.94 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $9.11 in profit for every $100 of shareholder equity.
ROA
Krsnaa Diagnostics Limited generates $5.34 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Krsnaa Diagnostics Limited generates limited operating cash flow of $518.75M, signaling weaker underlying cash strength.
Free Cash Flow
Krsnaa Diagnostics Limited generates weak or negative free cash flow of $-516.98M, restricting financial flexibility.
FCF Per Share
Each share generates $-15.94 in free cash annually.
FCF Yield
KRSNAA.BO converts -2.90% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
22.21
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-4.43
vs 25 benchmark
P/B Ratio
Price to book value ratio
1.93
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.33
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.31
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.42
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.09
vs 25 benchmark
ROA
Return on assets percentage
0.05
vs 25 benchmark
ROCE
Return on capital employed
0.17
vs 25 benchmark
How KRSNAA.BO Stacks Against Its Sector Peers
| Metric | KRSNAA.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 22.21 | 28.45 | Better (Cheaper) |
| ROE | 9.11% | 763.00% | Weak |
| Net Margin | 10.49% | -45265.00% (disorted) | Strong |
| Debt/Equity | 0.31 | 0.34 | Neutral |
| Current Ratio | 1.42 | 2795.60 | Neutral |
| ROA | 5.34% | -16588.00% (disorted) | Weak |
KRSNAA.BO outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Krsnaa Diagnostics Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
164.51%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
166.08%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
120.15%
Industry Style: Defensive, Growth, Innovation
High Growth